High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
13,310
-440 (-3.20%)
At close: Sep 15, 2025
-3.20%
Market Cap143.02B
Revenue (ttm)74.65B
Net Income (ttm)10.56B
Shares Out10.63M
EPS (ttm)991.66
PE Ratio13.56
Forward PEn/a
Dividend100.00 (0.76%)
Ex-Dividend DateDec 27, 2024
Volume51,030
Average Volume43,437
Open13,610
Previous Close13,750
Day's Range13,000 - 13,620
52-Week Range11,130 - 16,590
Beta0.77
RSI60.93
Earnings DateNov 12, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.